SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001104659-19-041942
Filing Date
2019-07-26
Accepted
2019-07-26 06:31:49
Documents
5
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 20-F/A a19-13252_120fa.htm 20-F/A 1599999
2 EX-12.1 a19-13252_1ex12d1.htm EX-12.1 12494
3 EX-12.2 a19-13252_1ex12d2.htm EX-12.2 12466
4 EX-13.1 a19-13252_1ex13d1.htm EX-13.1 5624
5 EX-13.2 a19-13252_1ex13d2.htm EX-13.2 5550
  Complete submission text file 0001104659-19-041942.txt   1637297
Mailing Address C/O STIKEMAN ELLIOTT LLP 1155 RENE-LEVESQUE BLVD. WEST, 41ST FLR MONTREAL A8 H3B 3V2
Business Address C/O STIKEMAN ELLIOTT LLP 1155 RENE-LEVESQUE BLVD. WEST, 41ST FLR MONTREAL A8 H3B 3V2 843-900-3201
Aeterna Zentaris Inc. (Filer) CIK: 0001113423 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 20-F/A | Act: 34 | File No.: 001-38064 | Film No.: 19975880
SIC: 2834 Pharmaceutical Preparations